Baxter International, Inc. (BAX)
| Market Cap | 43.56B |
| Revenue (ttm) | 11.82B |
| Net Income (ttm) | 1.07B |
| Shares Out | 505.00M |
| EPS (ttm) | 2.07 |
| PE Ratio | 42.01 |
| Forward PE | 25.58 |
| Dividend | $0.98 |
| Dividend Yield | 1.13% |
| Trading Day | May 10 |
| Last Price | $86.96 |
| Previous Close | $86.62 |
| Change ($) | 0.34 |
| Change (%) | 0.39% |
| Day's Open | 87.18 |
| Day's Range | 86.82 - 87.57 |
| Day's Volume | 2,140,162 |
| 52-Week Range | 74.32 - 90.61 |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company's quarterly cash dividend to a rate of $0.28...
Baxter's (BAX) first-quarter results reflect robust performance across five of its business units.
Baxter (BAX) delivered earnings and revenue surprises of 18.75% and 1.73%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2021. “Baxter's medically essential pro...
Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Baxter's (BAX) first-quarter results are likely to reflect growth in its Acute Therapies business.
Baxter (BAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been recognized by the Global Inclusion Index in 11 countri...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Mini...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel...
DEERFIELD, Ill. & WASHINGTON--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, and the Central Area of The Links, Incorporated, an international not-for-...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2021 financial results on Thur...
Baxter (BAX) gets FDA approval for its AK 98 Hemodialysis machine that offers a compact, portable and easy-to-use system for dialysis providers.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation Artific...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 1...
Baxter International Inc (NYSE: BAX) has agreed to provide manufacturing services for Moderna Inc's (NASDAQ: MRNA) COVID-19 Vaccine. The agreement includes fill/finish sterile manufacturing services and...
DEERFIELD, Ill., AND CAMBRIDGE, Mass..--(BUSINESS WIRE)--Baxter BioPharma Solutions and Moderna announce agreement for fill/finish manufacturing of the Moderna COVID-19 Vaccine in the U.S.
Baxter (BAX) reported earnings 30 days ago. What's next for the stock?
Generation Investment Management, the firm co-founded by Al Gore (Trades, Portfolio) and David Blood, disclosed this month that its top four buys during the fourth quarter of 2020 included a new positio...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed David S. Wilkes, M.D., dean, University of Virginia Sc...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $...
Baxter's (BAX) fourth-quarter results reflect robust performance across five of its business units.
Baxter (BAX) delivered earnings and revenue surprises of 5.26% and 0.83%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Baxter International (NYSE:BAX) moved higher by 0.3% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 1700.00% over the past year to $0.80...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended December 31, 2020, an...
Baxter's (BAX) fourth-quarter performance is likely to reflect growth in its Acute Therapies business.
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, ...
According to the GuruFocus All-in-One Screener as of Jan. 15, the following Health Care stocks are popular among gurus.
We think that Baxter International currently is a better pick compared to Boston Scientific. BAX stock trades at about 3.6x trailing Revenues, compared to around 5.2x for Boston Scientific.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter BioPharma Solutions announced an agreement with Novavax to provide sterile manufacturing services for its COVID-19 vaccine candidate.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thu...
We believe that Baxter stock, a healthcare supply company, is a good buying opportunity at the present time. BAX stock trades near $80 currently and it is, in fact, down 16% from its pre-Covid high of $...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 39th Annual J.P. Morgan Healthcare Conference via webcast. José (Jo...
Baxter's (BAX) Vital Edge program enables AdventHealth Tampa to achieve cost savings.
TAMPA, Fla.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, and AdventHealth Tampa today announced that AdventHealth Tampa will realize approxim...
The MS Global Franchise Fund (Trades, Portfolio), which is part of investment bank Morgan Stanley (NYSE:MS), disclosed its third-quarter portfolio earlier this week.
Baxter's (BAX) latest site expansion is aimed at better serving its client and patient pool along with employment creation.
Baxter's (BAX) Homechoice Claria combines a simple user interface with the benefits of Sharesource.
BAX offers a broad portfolio of essential, life-saving healthcare products to treat acute and chronic illnesses. There is no other competitor in the space that competes with BAX in all of their businesses.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of the Homechoice Claria autom...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 3rd Annual HealthCONx virtual conference via webcast o...
Daniel Loeb (Trades, Portfolio) has revealed his portfolio for the third quarter. During the quarter, the guru added 20 new holdings, including PG&E Corp. (NYSE:PCG) and Microsoft Corp. (NASDAQ:MSFT).
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $...
Daniel Loeb (Trades, Portfolio)'s Third Point Management sold shares of the following stocks during the third quarter, which ended on Sept. 30.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today published its first Sustainability Accounting Standards Board (SASB) index, a vol...
LONDON--(BUSINESS WIRE)-- #GlobalIntravenousFluidBagsMarket--The Intravenous Fluid Bags Market will grow by $ 667.51 mn during 2020-2024
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical... [Read more...]
| Industry Medical Instruments & Supplies | Founded 1931 |
| CEO Jose Almeida | Employees 50,000 |
| Stock Exchange NYSE | Ticker Symbol BAX |
Financial Performance
In 2020, BAX's revenue was $11.67 billion, an increase of 2.74% compared to the previous year's $11.36 billion. Earnings were $1.10 billion, an increase of 10.09%.
Analyst Forecasts
According to 19 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is 93.50, which is an increase of 7.53% from the latest price.